J&J



Ebit تغيير تاريخ
AbbVie USD 5.24B 1.5B 2024-12
Abbott USD 2.18B 486M 2025-03
Amgen USD 4.03B 11M 2024-12
AstraZeneca USD 4.2B 119M 2024-12
Baxter International USD 419M 28M 2024-12
Bayer EUR 855M 588M 2024-12
Becton, Dickinson and Co. USD 1.24B 191M 2024-12
Biogen USD 644.1M 100.9M 2024-12
Boston Scientific USD 1.35B 99M 2025-03
Bristol-Myers Squibb USD 4.18B 30M 2025-03
CONMED USD 64.47M 15.27M 2024-12
Cooper Companies USD 241.9M 21.4M 2025-01
Dexcom USD 209.5M 2.5M 2024-12
Edwards Lifesciences USD 411.3M 56.6M 2025-03
Eli Lilly USD 5.63B 3.88B 2024-12
Gilead Sciences USD 2.89B 221M 2025-03
GlaxoSmithKline GBP 1.43B 1.33B 2024-12
Globus Medical USD 154.57M 9.9M 2024-12
Hologic USD 300.7M 4.2M 2024-12
Indivior 101M 92M 2024-12
Insulet USD 109.3M 21.2M 2024-12
Integra LifeSciences USD 94.35M 42.82M 2024-12
Intuitive Surgical USD 767.5M 160.2M 2025-03
J&J USD 7.39B 2.04B 2025-03
Medtronic USD 2.17B 128M 2025-01
Merck USD 5.22B 339M 2024-12
Merit Medical Systems USD 68.42M 1.23M 2025-03
Novartis USD 4.86B 286M 2024-12
Pfizer USD 4.62B 2.42B 2024-12
Regeneron Pharmaceuticals USD 1.57B 67.9M 2024-12
Roche Holding CHF 11.29B 2.68B 2024-06
Sanofi EUR 2.9B 824M 2025-03
Stryker USD 1.88B 521M 2024-12
Tandem Diabetes Care USD -581000 25.51M 2024-12
Teva Pharmaceutical Industries USD 1.17B 100M 2024-12
Vertex Pharmaceuticals USD 1.2B 108.8M 2024-12
Zimmer Biomet Holdings USD 623.2M 143M 2024-12
Zoetis USD 988M 30M 2024-12



J&J - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - Apr 2025.